70 related articles for article (PubMed ID: 17291486)
1. Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats.
Inkster ME; Cotter MA; Cameron NE
Eur J Pharmacol; 2007 Apr; 561(1-3):63-71. PubMed ID: 17291486
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.
Oltman CL; Davidson EP; Coppey LJ; Kleinschmidt TL; Yorek MA
Diabetes Obes Metab; 2009 Mar; 11(3):223-33. PubMed ID: 18564175
[TBL] [Abstract][Full Text] [Related]
3. Xanthine oxidase inhibitors and sepsis.
Ramos MFP; Monteiro de Barros ADCM; Razvickas CV; Borges FT; Schor N
Int J Immunopathol Pharmacol; 2018; 32():2058738418772210. PubMed ID: 29786457
[TBL] [Abstract][Full Text] [Related]
4. Effects of allopurinol on in vivo suppression of arthritis in mice and ex vivo modulation of phagocytic production of oxygen radicals in whole human blood.
Miesel R; Zuber M; Sanocka D; Graetz R; Kroeger H
Inflammation; 1994 Dec; 18(6):597-612. PubMed ID: 7843803
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol and the Risk of Diabetic Macular Edema among U.S. Veterans with Type 2 Diabetes.
Sutton SS; Magagnoli J; Cummings TH; Hardin JW; Ambati J
Ocul Immunol Inflamm; 2023 Feb; ():1-7. PubMed ID: 36749950
[TBL] [Abstract][Full Text] [Related]
6. The RhoA GTPase-activating protein DLC2 modulates RhoA activity and hyperalgesia to noxious thermal and inflammatory stimuli.
Chan FK; Chung SS; Ng IO; Chung SK
Neurosignals; 2012; 20(2):112-26. PubMed ID: 22204965
[TBL] [Abstract][Full Text] [Related]
7. Redox regulation in diabetic kidney disease.
Daehn IS; Ekperikpe US; Stadler K
Am J Physiol Renal Physiol; 2023 Aug; 325(2):F135-F149. PubMed ID: 37262088
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility to diabetic kidney disease is linked to promoter variants of XOR.
Wang Q; Qi H; Wu Y; Yu L; Bouchareb R; Li S; Lassén E; Casalena G; Stadler K; Ebefors K; Yi Z; Shi S; Salem F; Gordon R; Lu L; Williams RW; Duffield J; Zhang W; Itan Y; Böttinger E; Daehn I
Nat Metab; 2023 Apr; 5(4):607-625. PubMed ID: 37024752
[TBL] [Abstract][Full Text] [Related]
9. Garlic and allopurinol alleviate the apoptotic pathway in rats' brain following exposure to fipronil insecticide.
Bakr AA; Ali M; Ibrahim K
Environ Anal Health Toxicol; 2022 Dec; 37(4):e2022037-0. PubMed ID: 36916050
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the relationship between serum xanthine oxidase levels and type 2 diabetes: a cross-sectional study.
Hasan M; Fariha KA; Barman Z; Mou AD; Miah R; Habib A; Tuba HR; Ali N
Sci Rep; 2022 Dec; 12(1):20816. PubMed ID: 36460780
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic effect of two different
Rašeta M; Popović M; Čapo I; Stilinović N; Vukmirović S; Milošević B; Karaman M
RSC Adv; 2020 Mar; 10(17):10382-10393. PubMed ID: 35498606
[TBL] [Abstract][Full Text] [Related]
12. Analysis of maslinic acid and gallic acid compounds as xanthine oxidase inhibitors in isoprenaline administered myocardial necrotic rats.
Shaik AH; Shaik SR; Shaik AS; Daoud A; Salim M; Kodidhela LD
Saudi J Biol Sci; 2021 Apr; 28(4):2575-2580. PubMed ID: 33911968
[TBL] [Abstract][Full Text] [Related]
13. In silico design and synthesis of targeted rutin derivatives as xanthine oxidase inhibitors.
Malik N; Dhiman P; Khatkar A
BMC Chem; 2019 Dec; 13(1):71. PubMed ID: 31384818
[TBL] [Abstract][Full Text] [Related]
14. Endothelium-Dependent Hyperpolarization (EDH) in Diabetes: Mechanistic Insights and Therapeutic Implications.
Goto K; Kitazono T
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370156
[TBL] [Abstract][Full Text] [Related]
15. Bioactive Compounds Isolated from Marine Bacterium
Gómez-Betancur I; Zhao J; Tan L; Chen C; Yu G; Rey-Suárez P; Preciado L
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31288374
[TBL] [Abstract][Full Text] [Related]
16. Can allopurinol improve retinopathy in diabetic rats? Oxidative stress or uric acid; which one is the culprit?
Goharinia M; Zareei A; Rahimi M; Mirkhani H
Res Pharm Sci; 2017 Oct; 12(5):401-408. PubMed ID: 28974978
[TBL] [Abstract][Full Text] [Related]
17. Xanthine Oxidase Activity in Type 2 Diabetes Mellitus Patients with and without Diabetic Peripheral Neuropathy.
Miric DJ; Kisic BM; Filipovic-Danic S; Grbic R; Dragojevic I; Miric MB; Puhalo-Sladoje D
J Diabetes Res; 2016; 2016():4370490. PubMed ID: 27965983
[TBL] [Abstract][Full Text] [Related]
18. Differential Telomere Shortening in Blood versus Arteries in an Animal Model of Type 2 Diabetes.
Tajbakhsh S; Aliakbari K; Hussey DJ; Lower KM; Donato AJ; Sokoya EM
J Diabetes Res; 2015; 2015():153829. PubMed ID: 26346823
[TBL] [Abstract][Full Text] [Related]
19. Diabetic neuropathic pain: Physiopathology and treatment.
Schreiber AK; Nones CF; Reis RC; Chichorro JG; Cunha JM
World J Diabetes; 2015 Apr; 6(3):432-44. PubMed ID: 25897354
[TBL] [Abstract][Full Text] [Related]
20. Normalizing dysfunctional purine metabolism accelerates diabetic wound healing.
Weinstein AL; Lalezarzadeh FD; Soares MA; Saadeh PB; Ceradini DJ
Wound Repair Regen; 2015; 23(1):14-21. PubMed ID: 25571764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
